Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $1.3 Million - $1.47 Million
6,800 Added 200.0%
10,200 $2.16 Billion
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $637,976 - $701,250
3,400 New
3,400 $654 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Black Maple Capital Management LP Portfolio

Follow Black Maple Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Maple Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Black Maple Capital Management LP with notifications on news.